Stem cell therapy without the cells

Greg Maguire, Greg Maguire

Abstract

As an example of the burgeoning importance of stem cell therapy, this past month the California Institute for Regenerative Medicine (CIRM) has approved $70 million to create a new network of stem cell clinical trial centers. Much work in the last decade has been devoted to developing the use of autologous and allogeneic adult stem cell transplants to treat a number of conditions, including heart attack, dementia, wounds, and immune system-related diseases. The standard model teaches us that adult stem cells exists throughout most of the body and provide a means to regenerate and repair most tissues through replication and differentiation. Although we have often witnessed the medical cart placed in front of the scientific horse in the development of stem cell therapies outside of academic circles, great strides have been made, such as the use of purified stem cells(1) instead of whole bone marrow transplants in cancer patients, where physicians avoid re-injecting the patients with their own cancer cells.(2) We most often think of stem cell therapy acting to regenerate tissue through replication and then differentiation, but recent studies point to the dramatic effects adult stem cells exert in the repair of various tissues through the release of paracrine and autocrine substances, and not simply through differentiation. Indeed, up to 80% of the therapeutic effect of adult stem cells has been shown to be through paracrine mediated actions.(3) That is, the collected types of molecules released by the stem cells, called the secretome, or stem cell released molecules (SRM), number in the 100s, including proteins, microRNA, growth factors, antioxidants, proteasomes, and exosomes, and target a multitude of biological pathways through paracrine actions. The composition of the different molecule types in SRM is state dependent, and varies with cell type and conditions such as age and environment.

Keywords: SRM; antimicrobial; growth factors; paracrine; stem cells; systems therapeutic; transplants.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3925653/bin/cib-6-e26631-g1.jpg
Figure 1. Molecules do the work. A model shows the injection of SRM (molecules) directly to the injured tissue, vs. the injection of cells that then indirectly release the SRM (molecules) to the injured tissue. Direct injection of the SRM to the tissue allows for a precise dosing schedule in space and time, whereas injection of cells into the tissue is highly variable.

References

    1. Czechowicz A, Weissman IL. Purified hematopoietic stem cell transplantation: the next generation of blood and immune replacement. Immunol Allergy Clin North Am. 2010;30:159–71. doi: 10.1016/j.iac.2010.03.003.
    1. Tsao GJ, Allen JA, Logronio KA, Lazzeroni LC, Shizuru JA. Purified hematopoietic stem cell allografts reconstitute immunity superior to bone marrow. Proc Natl Acad Sci U S A. 2009;106:3288–93. doi: 10.1073/pnas.0813335106.
    1. Chimenti I, Smith RR, Li TS, Gerstenblith G, Messina E, Giacomello A, Marbán E. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res. 2010;106:971–80. doi: 10.1161/CIRCRESAHA.109.210682.
    1. Lee JW, Krasnodembskaya A, McKenna DH, Song Y, Abbott J, Matthay MA. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med. 2013;187:751–60. doi: 10.1164/rccm.201206-0990OC.
    1. Chien KR. Regenerative biology: heartbroken embryos heal. Nature. 2013;498:439–40. doi: 10.1038/nature12262.
    1. Sato T, Clevers H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science. 2013;340:1190–4. doi: 10.1126/science.1234852.
    1. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: the renaissance cell. Circ Res. 2009;105:1164–76. doi: 10.1161/CIRCRESAHA.109.209809.
    1. Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Sarwal M, Millan MT, Shizuru JA, Lowsky R, Engleman EG, Strober S. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant. 2012;12:1133–45. doi: 10.1111/j.1600-6143.2012.03992.x.
    1. Warriner RA, Cardinal M. Human fibroblast-derived dermal substitute: results from a treatment investigational device exemption (TIDE) study in diabetic foot ulcers. Adv Skin Wound Care. 2011;24:306–11. doi: 10.1097/01.ASW.0000399647.80210.61.
    1. Katagiri W, Osugi M, Kawai T, Ueda M. Novel cell-free regeneration of bone using stem cell-derived growth factors. Int J Oral Maxillofac Implants. 2013;28:1009–16. doi: 10.11607/jomi.3036.
    1. Dissaranan C, Cruz MA, Kiedrowski MJ, Balog BM, Gill BC, Penn MS, Goldman HB, Damaser MS. Rat mesenchymal stem cell secretome promotes elastogenesis and facilitates recovery from simulated childbirth injury. Cell Transplant. 2013
    1. Agopian VG, Chen DC, Avansino JR, Stelzner M. Intestinal stem cell organoid transplantation generates neomucosa in dogs. J Gastrointest Surg. 2009;13:971–82. doi: 10.1007/s11605-009-0806-x.
    1. Menge T, Zhao Y, Zhao J, Wataha K, Gerber M, Zhang J, Letourneau P, Redell J, Shen L, Wang J, et al. Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury. Sci Transl Med. 2012;4:161ra150. doi: 10.1126/scitranslmed.3004660.
    1. Maguire G, Friedman P, McCarthy D, Friedman R, Maniotis AJ. Stem cell released molecules and exosomes in tissue engineering. Procedia Engineering. 2013;59:270–8. doi: 10.1016/j.proeng.2013.05.121.
    1. Lai RC, Yeo RW, Tan KH, Lim SK. Exosomes for drug delivery - a novel application for the mesenchymal stem cell. Biotechnol Adv. 2013;31:543–51. doi: 10.1016/j.biotechadv.2012.08.008.
    1. Mead CA. Collective Electrodynamics. MIT Press, 2000.
    1. Noble D. The Music of Life. Oxford University Press, 2006.
    1. Lupski JR. Genetics. Genome mosaicism--one human, multiple genomes. Science. 2013;341:358–9. doi: 10.1126/science.1239503.
    1. Maguire G. Using a systems-based approach to overcome reductionist strategies in the development of diagnostics. Expert Rev Mol Diagn
    1. Barbour J, Pfister H. Mach’s Principle: From Newton's Bucket to Quantum Gravity (Einstein Studies). Birkhauser, 1995.
    1. Ainsworth C. Cell biology: Stretching the imagination. Nature. 2008;456:696–9. doi: 10.1038/456696a.
    1. Maniotis AJ, Chen CS, Ingber DE. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci U S A. 1997;94:849–54. doi: 10.1073/pnas.94.3.849.
    1. Maguire G, Connaughton V, Prat AG, Jackson GR, Jr., Cantiello HF. Actin cytoskeleton regulates ion channel activity in retinal neurons. Neuroreport. 1998;9:665–70. doi: 10.1097/00001756-199803090-00019.
    1. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126:677–89. doi: 10.1016/j.cell.2006.06.044.
    1. Solon J, Levental I, Sengupta K, Georges PC, Janmey PA. Fibroblast adaptation and stiffness matching to soft elastic substrates. Biophys J. 2007;93:4453–61. doi: 10.1529/biophysj.106.101386.
    1. Maguire G, Friedman P. The Systems Biology of Stem Cell Released Molecules-Based Therapeutics. ISRN Stem Cells, 2013.
    1. Kathju S, Gallo PH, Satish L. Scarless integumentary wound healing in the mammalian fetus: molecular basis and therapeutic implications. Birth Defects Res C Embryo Today. 2012;96:223–36. doi: 10.1002/bdrc.21015.
    1. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:1650–9. doi: 10.1056/NEJM198612253152606.
    1. Lorenz HP, Longaker MT, Perkocha LA, Jennings RW, Harrison MR, Adzick NS. Scarless wound repair: a human fetal skin model. Development. 1992;114:253–9.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa